berberine has been researched along with d-alpha tocopherol in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Gastaldello, J; Grimm, SK; Kolodzik, A; Mracek, P; Nasiri, HR; Ullmann, D | 1 |
Iijima, OT; Matsumiya, T; Takeda, H | 1 |
Chen, W; Fan, DJ; Lin, X; Meng, LK; Miao, YQ; Tang, X; Yang, SS | 1 |
Chen, Y; Deng, J; Jia, X; Lv, H; Zhang, Z; Zhou, J | 1 |
Rajamanickam, VM; Singh, S; Vuddanda, PR; Yaspal, M | 1 |
Herbas, MS; Ishida, N; Kume, A; Shichiri, M; Suzuki, H | 1 |
Elbayoumi, TA; Kim, JJ; Shen, R; Yao, M | 1 |
Bellentani, S; Cicero, AFG; Colletti, A | 1 |
Elbayoumi, T; Yao, M | 1 |
Gu, L; Wang, GP; Yagiz, Y | 1 |
1 review(s) available for berberine and d-alpha tocopherol
Article | Year |
---|---|
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Topics: Antioxidants; Berberine; Curcumin; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Observational Studies as Topic; Plant Extracts; Probiotics; Randomized Controlled Trials as Topic; Resveratrol; Salvia miltiorrhiza; Silymarin; Ubiquinone; Vitamin D; Vitamin E; Xanthophylls | 2018 |
1 trial(s) available for berberine and d-alpha tocopherol
Article | Year |
---|---|
Emulsification by vitamin E TPGS or Quillaja extract enhanced absorption of berberine without affecting its metabolism in humans.
Topics: Berberine; Cross-Over Studies; Female; Humans; Male; Plant Extracts; Powders; Quillaja; Tandem Mass Spectrometry; Vitamin E | 2022 |
8 other study(ies) available for berberine and d-alpha tocopherol
Article | Year |
---|---|
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
Topics: | 2017 |
Effects of San'o-shashin-to on the antioxidative mechanism in spontaneous familial hypercholesterolaemic rabbits.
Topics: Animals; Antioxidants; Berberine; Drugs, Chinese Herbal; Erythrocyte Membrane; Hypercholesterolemia; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Oxidation-Reduction; Plant Extracts; Rabbits; Vitamin E | 2000 |
Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.
Topics: Administration, Oral; Animals; Berberine; Biological Availability; Drug Carriers; Drug Synergism; Intestinal Absorption; Male; Polyethylene Glycols; Random Allocation; Rats; Rats, Wistar; Vitamin E | 2011 |
Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dosage Forms; Drug Carriers; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Microscopy, Electron, Scanning; Phospholipids; Polyethylene Glycols; Rats, Sprague-Dawley; Silicon Dioxide; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Vitamin E | 2014 |
Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles.
Topics: Berberine; Drug Carriers; Hemolysis; Humans; Materials Testing; Nanoparticles; Particle Size; Plasma; Spectroscopy, Fourier Transform Infrared; Vitamin E | 2014 |
Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection.
Topics: alpha-Tocopherol; Animals; Anticholesteremic Agents; Antimalarials; Berberine; Cholestyramine Resin; Ezetimibe; Female; Malaria; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Parasitemia; Plasmodium yoelii; Probucol; Specific Pathogen-Free Organisms; Vitamin E Deficiency | 2016 |
Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Colon; Drug Liberation; Humans; Micelles; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Solubility; Spheroids, Cellular; Time Factors; Vitamin E | 2016 |
Anionic and Cationic Vitamin E-TPGS Mixed Polymeric Phospholipid Micellar Vehicles.
Topics: Antineoplastic Agents; Berberine; Cell Line, Tumor; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Male; Micelles; Nanoparticles; Nanostructures; Phospholipids; Prostatic Neoplasms; Solubility; Vitamin E | 2019 |